The last decade has seen increasing awareness of the problems encountered in diagnosis and management of the different forms of neurofibromatosis.1 2 Modern techniques of clinical and laboratory investigation have been applied to the disease, culminating in 1987 with the mapping of the genes for type 1 4 and type 25 6 neurofibromatosis to chromosomes 17 and 22 respectively. In the short term this means closely linked DNA markers can be used for prenatal and presymptomatic diagnosis and in the long term the cloning of the actual genes will be a major step towards our understanding of the pathogenesis of and possible treatments for the two main types of neurofibromatosis.
Nomenclature
Riccardi has suggested that there may be seven or more different forms of neurofibromatosis. The age range at which these can occur is also presented (unless obvious) 6 Complication Frequency
Age range of presentation (%) (years) The NIH Consensus Development Conference addressed these problems and recommended that neurofibromatosis type 1 sufferers should have an annual clinical assessment to monitor for complications. It was felt that screening investigations, such as cranial computed tomography, were not justified unless there were clinical indications. As many of the disease complications develop in childhood it is this author's present practise to recommend biannual review for children. Examination should be geared to monitoring for development of complications, therefore paying particular attention to blood pressure measurement and to examination of the spine and nervous system (particularly for signs of an optic glioma). As educational problems are so frequent a preschool psychological assessment seems appropriate.
There is no specific treatment for neurofibromatosis type 1 and most complications are managed in exactly the same way as when they occur in isolation. Plexiform neurofibromas, which are rarely seen as isolated lesions, are one of the most frequent complications and present a difficult management problem. They present as diffuse ill defined swellings often with overlying skin hypertrophy or pigmentation. As 
